The CareStart™ COVID-19 MDx RT-PCR molecular test provides a critical new resource in the fight against COVID-19 with a processing time of approximately 83 minutes.
The CareStart™ COVID-19 MDx RT-PCR test is an FDA EUA authorized molecular test for distribution and use by healthcare professionals and health systems conducting COVID-19 testing with 100% PPA/NPA results.
Analysis can be run on some of the most common PCR processing machines, such as Bio-Rad’s CFX96 Dx system, Thermo Fisher Scientific’s Applied Biosystems 7500, or 7500 Fast RT-PCR instrument.
- Detect two gene regions and simultaneously detect N gene as well as RdRP gene of SARS-2 CoV.
- Preventing contamination using the UDG (UracilDNA Glycosylase System).
- Internal control included for sample extraction and amplification efficiency verification
- Reaction time within 83 minutes improving laboratory efficiency.
Product Specifications and Resources
|Analyte||2019-Novel CoV (COVID-19)|
|Specimen type||Nasopharyngeal swab, Oropharyngeal swab|
|Sample volume||10 μL RNA|
|Internal control||Endogenous internal control included|
|Quality control||Positive control, Negative control|
|4 X 1 step RT-PCR Mix|
|2019-nCoV primer/probe Mix|
|Nuclease Free Water|
|MS2 Phage Control|